Study of IMC-S118AI in Type 1 Diabetes
← catalyst calendarNCT07493122 · readout ≤ 1,564 d
Sponsored by Immunocore Ltd (industry) · IMCR — their whole pipeline →.
Phase
Phase 1
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Single · Treatment
Enrollment
154estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Apr 2026 | estimated | When the study began enrolling |
| Primary completion | Nov 2030 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Nov 2030 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-25 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Type 1 Diabetes
- Type 1 Diabetes (T1D)
- Diabetes Type 1
Intervention
- Biological: IMC-S118AI
Primary outcomes
what the primary-completion date above is the date OFNumber of participants with ≥1 treatment-emergent serious adverse event (SAE)
measured Up to 60 weeks
Number of participants with ≥1 treatment-emergent adverse event (AE)
measured Up to 45 weeks
Number of participants with clinically significant changes in safety laboratory parameters
measured Up to 45 weeks
Number of participants with clinically significant changes in vital signs
measured Up to 45 weeks
Number of participants with clinically significant changes in electrocardiogram (ECG)
measured Up to 45 weeks
Number of participants with dose interruptions, reductions, or discontinuations
measured Up to 21 weeks
Permalink · IMCR's whole pipeline · Catalyst calendar · Every registered study · What changed